Moore Capital Management LP Buys Shares of 687,038 Ralliant Corporation $RAL

Moore Capital Management LP purchased a new position in shares of Ralliant Corporation (NYSE:RAL - Free Report) in the second quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund purchased 687,038 shares of the company's stock, valued at approximately $50,587,000. Ralliant accounts for about 0.8% of Moore Capital Management LP's portfolio, making the stock its 21st biggest position. Moore Capital Management LP owned about 0.62% of Ralliant as of its most recent SEC filing.

Several other institutional investors and hedge funds also recently modified their holdings of RAL. Dunhill Financial LLC acquired a new position in shares of Ralliant in the 2nd quarter worth approximately $25,000. Global Retirement Partners LLC bought a new stake in Ralliant during the second quarter worth approximately $35,000. Group One Trading LLC bought a new stake in Ralliant during the second quarter worth approximately $36,000. Danske Bank A S acquired a new position in Ralliant in the fourth quarter worth approximately $25,000. Finally, Persistent Asset Partners Ltd acquired a new position in Ralliant in the second quarter worth approximately $37,000.

Ralliant Stock Down 0.1%

RAL stock opened at $61.65 on Monday. The company has a debt-to-equity ratio of 0.75, a current ratio of 1.52 and a quick ratio of 1.00. The firm has a market capitalization of $6.82 billion, a P/E ratio of -5.68, a P/E/G ratio of 2.29 and a beta of 1.61. Ralliant Corporation has a 52-week low of $37.27 and a 52-week high of $75.41. The company's 50 day simple moving average is $68.40 and its 200-day simple moving average is $56.53.

Ralliant (NYSE:RAL - Get Free Report) last posted its quarterly earnings data on Thursday, July 30th. The company reported $0.68 EPS for the quarter, topping analysts' consensus estimates of $0.63 by $0.05. Ralliant had a negative net margin of 56.38% and a positive return on equity of 14.97%. The firm had revenue of $567.80 million during the quarter. Ralliant has set its FY 2026 guidance at 2.760-2.900 EPS and its Q3 2026 guidance at 0.720-0.780 EPS. As a group, equities research analysts anticipate that Ralliant Corporation will post 2.87 EPS for the current year.

Ralliant Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Wednesday, September 23rd. Stockholders of record on Tuesday, September 8th will be given a $0.05 dividend. This represents a $0.20 annualized dividend and a dividend yield of 0.3%. The ex-dividend date of this dividend is Tuesday, September 8th. Ralliant's dividend payout ratio (DPR) is -1.84%.

Wall Street Analysts Forecast Growth

A number of brokerages have recently commented on RAL. Truist Financial reiterated a "buy" rating and set a $82.00 price objective (up from $68.00) on shares of Ralliant in a research report on Friday, July 31st. Vertical Research cut Ralliant from a "buy" rating to a "hold" rating and set a $65.00 target price on the stock. in a report on Wednesday, May 27th. Royal Bank Of Canada boosted their target price on Ralliant from $71.00 to $73.00 and gave the stock a "sector perform" rating in a research report on Friday, July 31st. Evercore assumed coverage on Ralliant in a report on Tuesday, June 9th. They set an "outperform" rating and a $80.00 target price for the company. Finally, Barclays increased their price target on Ralliant from $52.00 to $67.00 and gave the company an "overweight" rating in a research report on Wednesday, May 13th. One research analyst has rated the stock with a Strong Buy rating, seven have issued a Buy rating, three have given a Hold rating and one has given a Sell rating to the company's stock. Based on data from MarketBeat, Ralliant has an average rating of "Moderate Buy" and an average price target of $75.70.

Insiders Place Their Bets

In related news, SVP Karen M. Bick sold 6,062 shares of the stock in a transaction dated Monday, August 17th. The stock was sold at an average price of $72.00, for a total value of $436,464.00. Following the completion of the sale, the senior vice president directly owned 31,668 shares of the company's stock, valued at approximately $2,280,096. This represents a 16.07% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CEO Tamara S. Newcombe sold 12,936 shares of the firm's stock in a transaction dated Friday, August 14th. The stock was sold at an average price of $71.79, for a total value of $928,675.44. Following the sale, the chief executive officer owned 251,967 shares of the company's stock, valued at $18,088,710.93. The trade was a 4.88% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders own 0.42% of the company's stock.

Ralliant Company Profile

Ralliant, Inc NYSE: RAL is a medical technology company focused on enabling point-of-care cell therapy solutions in the field of regenerative medicine. The company develops and markets systems that isolate, concentrate and store adipose-derived stromal vascular fraction (SVF) cells directly from a patient's own fat tissue, facilitating same-day, autologous treatments without the need for extensive laboratory infrastructure.

The company's core product portfolio includes proprietary device platforms and single-use processing kits engineered to streamline the workflow for clinicians.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source